Next Page arrow_forward
APUS published a regulatory filing. Review the primary filing for the reported company update.
Read source-backed briefTickerStar monitors official filings, investor releases, earnings, and call updates for APUS. Subscribe to APUS alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.
TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.
APUS published a regulatory filing. Review the primary filing for the reported company update.
Read source-backed briefApimeds Pharmaceuticals US, Inc. has filed its definitive proxy statement for the 2026 Annual Meeting of Stockholders scheduled for December 23, 2026 at 9:30 a.m. Eastern Time as a completely virtual meeting. Stockholders of record as of November 20, 2026 will vote on the election of four directors, ratification of Kreit & Chiu CPA LLP as independent auditor for fiscal year 2026, and an adjournment proposal. The Board unanimously recommends voting FOR all proposals.
Read source-backed briefApimeds Pharmaceuticals US reported Q3 2026 revenue of $2.89 million and operating income of $2.0 million, its first full quarter of revenue from technology services following the disposal of its former biopharmaceutical subsidiary on July 14, 2026. Net income was $33.6 million, or $19.13 per basic share and $7.68 per diluted share, which includes a $25.26 million unrealized gain on digital assets. The company disclosed substantial doubt about its ability to continue as a going concern due to a $10.5 million sen...
Read source-backed briefAPUS filed its 10-Q; the most relevant disclosure change is expanded Discontinued operations and deconsolidation: Lokahi Therapeutics Inc. was deconsolidated on July 14, 2026 upon merger with Glucotrack, Inc.; company received 37,884 Glucotrack common shares and rights to 2,269,100 Series A preferred shares (as converted), measured at $962,935 total fair value; gain on de. Customer concentration: Two customers (Customer A and Customer B) represented 100% of revenue; Two customers represented 100% of accounts_rec...
Read source-backed brief